Cancer multidrug resistance (MDR) occurs when cancer cells evade the cytotoxic actions of chemotherapeutics through the active efflux of drugs from within the cells. Our group have previously demonstrated that multidrug-resistant breast cancer cells spontaneously shed microparticles (MPs) and that these MPs can transfer resistance to drug-responsive cells and confer MDR on those cells in as little as 4 h. Furthermore, we also showed that, unlike MPs derived from leukaemia cells, breast cancerÁderived MPs display a tissue selectivity in the transfer of P-glycoprotein (P-gp), transferring the resistance protein only to malignant breast cells. This study aims to define the proteome of breast cancerÁderived MPs in order to understand the differences in protein profiles between those shed from drug-resistant versus drug-sensitive breast cancer cells. In doing so, we detail the protein cargo required for the intercellular transfer of MDR to drug-sensitive recipient cells and the factors governing the transfer selectivity to malignant breast cells. We describe the first proteomic analysis of MPs derived from human breast cancer cells using SDS PAGE and liquid chromatographyÁtandem mass spectrometry (LC/MS/MS), in which we identify 120 unique proteins found only in drug-resistant, breast cancerÁderived MPs. Our results demonstrate that the MP-mediated transfer of P-gp to recipient cells occurs alongside CD44; the Ezrin, Radixin and Moesin protein family (ERM); and cytoskeleton motor proteins within the MP cargo.
transfer of P-gp, transferring the resistance protein to malignant breast cells only (13) .
MPs are small membrane vesicles arising from membrane budding and are observed in most cell types during apoptosis or upon cell activation (14) . MPs serve an important role in physiology, specifically in maintaining haemostasis (15) . They are also mediators in various disease states, including hypercoagulation and thromboembolism (16) , inflammation (17) , diabetes (18) , HIV-1 (19) and cancer (20) .
Interaction between proteins associated with the plasma membrane and the cytoskeleton is crucial in cell adhesion, cell signalling, membrane trafficking, cell motility, apoptosis and MP formation (21Á23). A family of closely related proteins, the ERM (Ezrin, Radixin and Moesin) proteins, play an extensive role in these processes and possess a unique module required to interface and crosslink membrane proteins with the cytoskeleton (21, 23) .
This research defines the proteome of breast cancerÁ derived MPs and compares the protein content of MPs shed from drug-sensitive cells with their drug-resistant counterparts. In doing so, we establish the protein cargo required for the intercellular dissemination of MDR by MPs and identify the protein signature associated with the selectivity of P-gp transfer by resistant breast cancerÁ derived MPs.
Materials and methods

Cell culture
The drug-sensitive human breast adenocarcinoma cell line MCF-7 and the drug-resistant cell line MCF-7/Dx were used in these studies. The cell lines have been validated as appropriate models for the study of P-gp-mediated MDR in vitro and in vivo (13) . Cells were cultured in RPMI 1640 medium (Sigma-Aldrich), supplemented with 10% (v/v) heat-inactivated foetal bovine serum (Life Technologies) and maintained in the absence of antibiotics at 378C and 5% CO 2 .
Harvesting MPs
We have extensively described the isolation and validation of the MP population for morphology, size and resistance protein expression previously, using scanning electron microscope (24, 25) and flow cytometric analysis (FCM) (6,13,24Á26) . Likewise in this study, MPs were gated based on size (Fig. 1) . Thirty-four percent of the gated population detected positive for P-gp expression using an antibody selective for the external epitope. This is consistent with our previous findings for these MPs (13, 25) . The procedure for isolation of MPs was as described by us in Refs. (6,13,24Á26) . In brief, after the cells have reached confluence, the supernatant containing cells and MPs was collected and centrifuged for 5 min at 500 g to remove cell and cell debris. The supernatant was further centrifuged for 5 min at 500 g and 1 h at 15,000 g at 178C to pellet MPs. The pellet was washed in serum-free media and centrifuged for 2 min at 2,000 g to remove debris. The media containing MPs were further centrifuged for 30 min at 18,000 g at 178C, and the pellet was resuspended in serumfree RPMI-1640 and/or low-volume of alkaline extraction reagent (pH 8.8) containing 7 M urea, 2 M thiourea, 50 mM tris(hydroxymethyl)methylamine-HCl and 1% C7BzO in a 10 mL final volume of water (27) . MPs resuspended in serum-free RPMI-1640 were validated by FCM (LSRII, BD Biosciences, CA, USA) by P-gp (clone 17F9, BD Biosciences, Australia) staining as described in Ref. (25) .
Protein extraction
The pellet, resuspended in a low volume of alkaline extraction, was sonicated 4 times for 30 sec at 40% power, using a high-intensity ultrasonic processor (50 watt, Sonics and Materials Inc., USA). The samples were reduced and alkylated in the alkaline protein solution by adding tributylphosphine solution to a final concentration of 5 mM (1:40 dilution) and acrylamide monomers to a final concentration of 20 mM (1:50 dilution). The reaction was quenched by adding 1 M dithiothreitol solution (final concentration: 20 mM) and centrifuged at 17,000 g for 5 min to pellet any undissolved material. Finally, the protein was precipitated with 5 volumes of acetone before resuspension in 1% SDS (sodium dodecyl sulphate). Total protein concentration was determined using a Qubit fluorometer (Invitrogen) as per the manufacturer's protocol.
SDS-PAGE and trypsin in-gel digestion
One hundred micrograms of extracted MP proteins was mixed with 2) SDS sample buffer containing Tris-HCl, glycerol, SDS, bromophenol blue and water (pH 8.8) at the ratio of 2:1 (proteinÁSDS buffer), and sonicated in a water-bath for 5 min followed by centrifugation for 5 min at 16,500 g, room temperature. Proteins were separated using a 4Á10% gel at a voltage of 150 V in MES SDS running buffer (Invitrogen). The gel was fixed with 40% methanolÁ10% acetic acid for 30 min with gentle shaking before staining with Coomassie blue overnight. In-gel trypsin digestion was performed as described in Ref. (27) . Briefly, the gel (Supplementary file 1) was sectioned according to the MW markers into 12 different sections, and the sections diced into 1)1 mm pieces which were then de-stained by adding 50% acetonitrile (ACN)Á 50 mM NH 4 HCO 3 and incubating for 10 min at room temperature. The process was repeated until the colour disappeared. One hundred percent ACN was added to dehydrate the gel pieces before rehydration with 12.5 ng/mL of trypsin solution (Trypsin gold-MS grade, Promega) and overnight incubation at 378C. After incubation, the supernatant was collected after sonication in a waterbath for 10 min, followed by another sonication after the addition of 30 mL of 50% ACNÁ2% formic acid.
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The solution was added to the previously collected peptides, and the volume reduced to 15 mL by rotary evaporation. The peptide solution was centrifuged at 14,000 g for 10 min to remove any insoluble material prior to LC/MS/MS analysis.
Western blotting
Twenty micrograms of total cellular and MP proteins were separated on SDS-PAGE, as described earlier, before transferring to PVDF membrane (Pall Australia, VIC, Australia). The membrane was blocked overnight with 5% skim milk in PBS and 0.05% Tween 20, and then incubated with anti-P-gp mAb (clone F4; Sigma-Aldrich), anti-Ezrin mAb (clone 3C12; Life Science), anti-Moesin mAb (clone 38/87; Sigma-Aldrich), anti-radixin pAb (SAB2500859; Sigma-Aldrich) or CD44 mAb (clone EPR1013Y; Abcam) for 1 h. Anti-b-actin (clone AC-74; Sigma-Aldrich) was used as the internal control, followed by horseradish peroxidase conjugates secondary antibody. Protein expression was visualized using an ECL (enhanced chemoluminescence) system (Roche Applied Science, NSW, Australia). The membranes were imaged using the luminescent image analyser LAS-3000 (Fujifilms, Brookvale, NSW, Australia).
LC/MS/MS
Using an Eksigent AS-1 autosampler connected to a Tempo nanoLC system (Eksigent, USA), 10 mL of the sample was loaded at 20 mL/min with MS loading solvent (2% ACN'0.2% trifluoroacetic acid) onto a C8 trap column (CapTrap, Michrom Biosciences, USA). After washing the trap for 3 min, the peptides were washed off the trap at 300 nL/min with MS solvent A (2% ACN' 0.2% formic acid) onto a PicoFrit column (75)150 mm, New Objective) packed with Magic C18AQ resin (Michrom Biosciences). Peptides were eluted from the column and into the source of a QSTAR Elite hybrid quadrupoletime-of-flight mass spectrometer (ABSciex) using the following program: 5Á50% MS solvent B (98% ACN'0.2% formic acid) over 30 min, 50Á80% MS solvent B over 5 min, 80% MS solvent B for 2 min and 80Á5% for 3 min. The eluting peptides were ionized from the PicoFrit column at 2300 V. An Intelligent Data Acquisition (IDA) experiment was performed, with a mass range of 350Á1,500 Da continuously scanned for peptides of charge state 2 ' Á5 ' with an intensity of more than 30 counts/s. Selected peptides were fragmented, and the product ion fragment masses measured over a mass range of 100Á1,500 Da. The mass of the precursor peptide was then excluded for 15 sec.
Data analysis
Three biological replicates of total MP proteins were analysed by LC-MS/MS, and the MS/MS data files produced by the QSTAR Elite were searched using Mascot Daemon (version 2.3, provided by the Walter and Eliza Hall Institute, (28) . Peptide identifications were accepted if they could be established at greater than 95.0% probability as specified by the Peptide Prophet algorithm (29) . Protein identifications were accepted if they could be established at greater than 95.0% probability and contained at least 2 identified peptides in 2 replicates. Protein probabilities were assigned by the Protein Prophet algorithm (30) . Proteins that contained similar peptides and could not be differentiated based on MS/MS analysis alone were clustered by Scaffold to satisfy the principles of parsimony.
Results and discussion
The production and secretion of extracellular vesicles or MPs are universal cellular processes that have been described in bacteria, archaea and eukaryotes (31, 32) . MPs package proteins, DNA and RNA, and they display a variety of cell surface markers. These features affect how MPs identify target cells and the composition of the cargo they transport to sites distal from their origin (33) . In higher eukaryotes, MPs have a range of pathophysiological roles in cancer, infectious disease, systemic lupus, arthritis and neurodegenerative disorders, and their presence has been detected in most body fluids (31, 34) . Because of their informational content, MPs have been described as signalosomes (31) . MPs are involved in tumour spread (35) and trigger tumour growth by stimulating the proliferation of cancerous cells by inducing angiogenesis in neighbouring endothelial cells (36) . Previous work in our laboratory has shown for the first time that purified MPs transfer functional P-gp from drugresistant cancer cells to drug-sensitive cells (6) . We were able to show that MPs can confer mRNA, which has implications in the transfer and dominance of cancer traits (11, 24) . In breast cancer, MPs show tissue selectivity by transferring P-gp only to malignant breast cancer cells but not to other cells (13) . We set out to profile the proteome of MPs derived from breast cancer cells to identify proteins involved in MDR transfer. Thus, in this study, we applied a conceptually unbiased proteomic approach to interrogate the protein content of MPs purified from isogenic breast cancerÁderived lines that differ in their resistance profile from a broad range of drugs. Initially, more than 600 proteins were identified in both samples. Applying a stringent criterion for protein validation of a minimum of 2 peptides in at least 2 technical replicates reduced the final analysis to 270 total proteins. Of the 270, 249 proteins belong to MCF-7/Dx-MPs and 150 proteins belong to MCF-7-MPs, with 129 common to both (Fig. 2,  Supplementary file 2) . The unique proteins identified in this experiment were also consistent with the Western blot data shown in Fig. 3 . We observed a selective packaging of ERM and CD44 proteins in MCF-7/Dx-MPs relative to MCF-7-MPs consistent with our LC-MS/MS data (Table I ). Our findings with ezrin are consistent with our previous study that ezrin is present in MP cargo isolated from resistant cells (13) . In the context of breast cancer, the selective packaging of these proteins in MCF-7/Dx-MPs and not in MCF-7-MPs suggests that these cytoskeletal elements are required in stabilizing P-gp in the MP cargo en route to the recipient cells. This is consistent with previous publications, which show a role for the FERM domain-binding proteins and CD44 in P-gp membrane localization (22, 52) . This finding expands our knowledge of the required protein signature for P-gp transfer by MPs. Gene ontology of the unique proteins identified from drug-resistant MPs was generated according to their annotated (a) cellular component, (b) biological process and (c) molecular function. Besides protein profiling, our interest was to identify candidate proteins that may contribute to the ability of MPs to transfer MDR. The proteins unique to drug-resistant cell MPs were investigated for documented evidence of an association with P-gp and enhancement of drug-resistant activity. Nineteen cytoskeletal proteins, including vimentin, talin-1, coronin 1C and members of the ERM family, were identified. KEGG pathway analysis was able to classify 10 of the unique proteins to the ''regulation of actin cytoskeleton'' pathway. Those 10 proteins are myosin-9, vinculin, moesin, actin 4, ezrin, integrin beta 3, fibronectin, ras-related C3 botulinum toxin substrate 1 (rho family), IQ motif containing GTPase activating protein 1 and myosin light chain 12B regulatory protein. Most of the cytoskeletal-associated proteins identified possess an N-terminally located FERM domain (4.1 protein, Ezrin, Radixin and Moesin), which plays a key role in linking actin fibres to the plasma membrane. Forty-five proteins related to or known to localize to the plasma membrane were also identified, including multidrug-resistant protein 1, stomatin, aminopeptidase, sarcoplasmicÁendoplasmic reticulum calcium ATPase 2, ecto-5?-nucleotidase and glutathione S-transferase P1 (GSTP1). Ecto-5?-nucleotidase (CD73), a membrane-associated glycoprotein that generates adenosine by hydrolysing 5?-AMP to adenosine, has been implicated in metastasis-promoting activities, including tumour angiogenesis and vasodilation, adhesion of lymphocytes to endothelial cells and adhesion, invasion and migration of human breast cancer cells (38, 53, 54) . Increased levels of CD73 protein expression were reported in several MDR cell lines, suggesting that this enzyme is involved in drug resistance (39, 55) . Expression of various isoforms of glutathione SÁtransferase P1 is enhanced in adenocarcinoma cells during their transition to a drug-resistant state (40) . Involvement of these proteins is likely to play an important role in intracellular trafficking of P-gp within recipient cells because P-gp is localized not only in the plasma membrane but also in intracellular compartments, including the endoplasmic reticulum, golgi, endosomes and lysosomes (56) .
The FERM domain is found in a number of cytoskeletal-associated proteins, including Band 4.1, ezrin, radixin, moesin, DAL-1, talin-1, merlin, focal adhesion kinase (FAK) and the proline-rich tyrosine kinase 2 (PYK2) (41) . This specialized group of macromolecules is found in higher order structures, including sites of cellÁcell and cellÁextracellular matrix attachment (42, 57) . Ezrin, radixin, moesin and talin-1 were found in MPs derived from drug-resistant cells only. The Nterminally located FERM domain binds to cytosolically exposed C-terminal regions of integral membrane proteins, and C-terminal domains in FERM proteins bind actin (43, 58) . Interactions between the plasma membrane and the cytoskeleton are essential in cell adhesion, cell signalling, membrane trafficking, cell motility, apoptosis and MP formation (21Á23). The presence of FERM domain proteins in drug-resistant MPs indicates that they are likely to play a key role in the mechanism by which MPs transfer an MDR phenotype.
There are several key observations that support the contention that MDR involves changes to cytoskeletal structure. These include (a) the observation that MDR Fermitin family homolog 2 6 (4) 10 Enhances integrin-mediated cell adhesion onto the extracellular matrix and cell spreading (51).
Proteins identified from MPs derived from drug-resistant breast cancer cells, which are reported in the literature to directly or indirectly contribute to cancer and/or MDR. The list is generated with the total unique peptide count and the protein coverage to determine the percentage of the residues in each protein sequence.
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osteosarcoma cells exhibit an increase in actinÁstress fibre organization which, when disrupted, sensitizes cells to anticancer drugs (59); (b) P-gp translocates to the plasma membrane and co-localizes with ezrin in IFN-g treated, monocyte-derived macrophages (60); (c) the colocalization of P-gp with ERM proteins occurs on pseudopods and uropods in resistant lymphoid cells (22) , and disruption of the ERMÁP-gp association was shown to impair P-gp function and resulted in the cellular redistribution of P-gp (22); (d) an actinÁP-gp interaction is essential for endosomal trafficking of P-gp (61); and (e) P-gp binds ezrin at amino acid residues 149Á242 in the FERM domain, and the disruption of this interaction results in P-gp relocation from the plasma membrane to the cytoplasm (62). CD44, stathmin 1 and fermitin family homolog 2 (FERMT2) proteins were identified exclusively in MCF-7/Dx-MPs. CD44 is the major surface receptor to hyaluronan and is implicated in cell adhesion, metastasis and motility (63, 64) . C-terminal regions of CD44 located intracellularly assemble with FERM domain proteins, including ezrin, radixin and moesin, that anchor CD44 to actin and influence downstream signalling pathways (37) . The ezrin binding site on CD44 has been mapped to 2 clusters of basic amino acids in a membrane-proximal 9-aminoacid region within the CD44 cytoplasmic domain (65) . CD44 and P-gp typically co-immunoprecipitate (52) , their expression in the cell is co-regulated (66) and both proteins are found co-localized to the plasma membrane (52) . Supporting this model of interaction, it has recently been proposed that P-gp complexes with activated CD44 via ERM intermediates (67) . Low-molecular-mass hyaluronic acid promotes the internalization of the CD44ÁERM protein complex, which is accompanied by decreased drug resistance (37) . These observations are supported by the STRING database (Fig. 4) , which shows P-gp interacting with CD44 along with GSTP1, tropomyosin 3 and CD73. CD44 also interacts with intercellular adhesion molecule 1 (ICAM 1), rho family, fibronectin 1, ezrin, moesin, integrin beta 3, vinculin, basigin and vimentin. These proteins have a role in promoting cancer cell proliferation and drug resistance. Vinculin modulates talin to help in cell adhesion by mediating integrin-mediated adhesion (46) . Integrins are cell surface receptors that participate in cellÁcell and cellÁextracellular matrix interactions and contribute to the aggressive behaviour of cancer cells (68) . We found integrin-b-3 in resistant cell MPs, whereas integrin-b-2 was present in both MP preparations. Integrins are also known to transmit chemical signals and have a role in cellular responses such as migration, survival, differentiation and motility (69) . Besides vinculin and talin, the kindlin family proteins also enhance integrin activation (70) . FERMT2 proteins, which belong to the kindlin family, were identified exclusively in MCF-7/Dx-MPs. Other MCF-7/Dx-specific MP proteins identified in our proteome analysis that have a role in promoting cancer cell proliferation and drug resistance included stathmin, aminopeptidase, phosphoserine aminotransferase and other proteins listed in Table I . Stathmin has a role in cell proliferation and participates in carcinogenesis of various carcinomas (48) , and aminopeptidases are reported to play a role in tumour invasion and are found to be elevated in the plasma and effusion of cancer patients (71) , whereas phosphoserine aminotransferase is reported to stimulate cell growth and increases the chemotherapy resistance of colon cancer cells (47) .
Conclusion
Previously, we have reported that resistance to anticancer drugs can be transferred by MPs from drug-resistant to drug-sensitive cells within a cancer cell population (6, 11, 12) in a tissue-selective manner (13) . In this work, we characterize the proteome of MPs derived from drugresistant versus drug-sensitive breast cancer cells and show that the proteome of MCF-7/Dx-MPs has an abundance of proteins previously reported to be involved in MDR. These findings reinforce our earlier observations and suggest that the transfer of MDR and specifically Pgp to recipient cells is facilitated by cytoskeletal proteins, actin binding proteins, glycolytic proteins, adhesion molecules and cytoskeletal motor proteins (Fig. 5 , Table II ). These findings bring us closer to identifying targets, which may be used in the design of selective therapeutics for the prevention of MDR clinically.
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